Export bans on vaccines legal challenges

Introduction

Export bans on vaccines are government-imposed restrictions that prevent or limit the supply of vaccines to foreign countries. Governments may introduce such restrictions during pandemics, public health emergencies, domestic shortages or national security situations. Their primary objective is generally to ensure sufficient vaccine availability for the domestic population. However, export restrictions can create serious legal challenges involving international trade obligations, public health responsibilities, contractual rights, equality and humanitarian considerations.

The legality of an export ban depends on its legal basis, duration, necessity, proportionality and compliance with domestic and international law.

Legal framework governing vaccine export restrictions

In India, the Foreign Trade (Development and Regulation) Act, 1992 provides the principal statutory framework for regulating exports. Under Section 3, the Central Government may make provisions for prohibiting, restricting or regulating exports through orders and notifications. The Foreign Trade Policy and applicable export-control notifications determine whether particular vaccines can be exported freely, subject to conditions or only with government permission.

The Drugs and Cosmetics Act, 1940 and applicable rules regulate the manufacture, quality and distribution of drugs, including vaccines. These laws establish regulatory standards but should not automatically be treated as independent authority for imposing every export prohibition.

At the international level, the World Trade Organization's General Agreement on Tariffs and Trade (GATT) 1994 is particularly important. Article XI generally prohibits quantitative restrictions on exports and imports. However, Article XI:2(a) permits temporary export prohibitions or restrictions designed to prevent or relieve critical shortages of foodstuffs or other products essential to the exporting country's needs. Whether a particular vaccine restriction qualifies depends on the circumstances and evidence supporting the shortage.

Article XX(b) may also justify measures necessary to protect human, animal or plant life or health, provided the measure satisfies the conditions in the Article's introductory paragraph, known as the chapeau. This requires that the measure not be applied in a manner constituting arbitrary or unjustifiable discrimination or a disguised restriction on international trade.

Major legal challenges against vaccine export bans

1. Violation of international trade obligations

A major challenge arises when an export ban is inconsistent with GATT Article XI. Other WTO members may argue that the restriction unnecessarily disrupts international vaccine supplies and violates international trade commitments.

A government defending the restriction must establish that an applicable exception is available. A temporary measure addressing a genuine critical shortage may receive stronger legal justification than an indefinite or discriminatory prohibition.

2. Conflict between domestic public health and global health responsibilities

Governments have a legitimate responsibility to protect their populations. However, vaccines are essential public health products, and restrictions can negatively affect countries that depend on imported supplies.

The legal challenge is balancing domestic constitutional and public health responsibilities with international cooperation. The International Health Regulations (2005) provide an important framework for international cooperation during public health emergencies, although they do not create a general, directly enforceable prohibition on vaccine export bans.

3. Contractual disputes and commercial liability

Vaccine manufacturers may have entered into supply agreements with foreign governments, international organisations or distributors. An export ban may prevent manufacturers from fulfilling those contracts.

Affected parties may pursue contractual remedies, depending on governing law, contractual clauses, force majeure provisions and dispute-resolution mechanisms. However, a government restriction does not automatically establish manufacturer liability where performance has become legally prohibited.

4. Discrimination and unequal treatment

Export restrictions may be challenged where they favour particular trading partners or discriminate between similarly situated countries without a legitimate justification. Under WTO law, the relevant obligations may include the most-favoured-nation principle under GATT Article I, depending on the measure and applicable exceptions.

Domestic constitutional principles may also become relevant where government decisions are arbitrary or lack a rational basis.

Important judicial and international decisions

1. European Communities – Measures Affecting the Approval and Marketing of Biotech Products (WTO, 2006)

This dispute concerned restrictions and delays affecting genetically modified products. Although it did not concern vaccine export bans, it demonstrates how regulatory measures affecting biotechnology products can be examined under WTO agreements. It is relevant by analogy when assessing whether restrictions on vaccine trade are scientifically justified and consistent with international obligations.

2. India – Quantitative Restrictions on Imports (WTO, 1999)

This dispute examined India's quantitative restrictions on imports. The WTO Appellate Body considered the relationship between trade restrictions and the exceptions available under GATT. Although the dispute concerned imports rather than vaccine exports, it illustrates that governments must establish the legal conditions for relying on trade exceptions.

3. Brazil – Measures Affecting Imports of Retreaded Tyres (WTO, 2007)

The WTO Appellate Body examined whether Brazil's import restrictions could be justified under GATT Article XX(b), which protects measures necessary to safeguard human, animal or plant life or health. The decision is relevant by analogy because it explains the necessity test and the requirement to avoid arbitrary or unjustifiable discrimination.

4. Vellore Citizens' Welfare Forum v. Union of India (1996)

The Supreme Court of India recognised the precautionary principle and polluter-pays principle as important elements of Indian environmental law. Although the case did not concern vaccines or exports, its discussion of preventive government action is relevant to understanding the legal importance of protecting public health where scientific risks exist.

Judicial review and remedies

In India, an affected party may challenge an arbitrary or legally unsupported government export restriction before the appropriate constitutional court. Articles 14 and 19(1)(g) may be relevant where the restriction involves arbitrary state action or unreasonable interference with business activities, subject to applicable constitutional limitations.

At the international level, WTO members may initiate consultations and dispute-settlement proceedings where they believe an export restriction violates WTO obligations. Private manufacturers generally cannot independently bring WTO disputes; such proceedings are initiated by member governments.

Conclusion

Export bans on vaccines involve a difficult balance between national public health protection and international trade responsibilities. Governments may impose temporary restrictions to address genuine domestic shortages, but such measures must have a valid legal foundation and satisfy applicable international exceptions. WTO rules, contractual obligations and constitutional principles provide important mechanisms for examining their legality. Ultimately, transparency, proportionality, non-discrimination and international cooperation are essential to ensuring that emergency vaccine restrictions remain legally defensible.